AbCellera to Present at Upcoming Investor Conferences in May and June 2026

Published: 2026-05-07 16:10:05 ET ABCL

Published on 05/07/2026 at 04:10 pm EDT

AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:

A live audio webcast of each presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website closer to date. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody-based medicines in the areas of endocrinology, women’s health, immunology, oncology, and more. For more information, please visit www.abcellera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260507687475/en/